Weighted Average Number of Shares Outstanding, Diluted of Marker Therapeutics, Inc. from 30 Sep 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Marker Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2011 to 30 Sep 2025.
  • Marker Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 16,757,678, a 88% increase year-over-year.
  • Marker Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 8,980,207, a 1.9% increase from 2023.
  • Marker Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 8,809,382, a 5.5% increase from 2022.
  • Marker Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 8,351,003, a 9.2% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Marker Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 16,757,678 +7,834,508 +88% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 13,956,562 +5,038,329 +56% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 11,106,027 +2,204,065 +25% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 8,980,207 +170,825 +1.9% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 8,923,170 +97,289 +1.1% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 8,918,233 +119,277 +1.4% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 8,901,962 +180,931 +2.1% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 8,809,382 +458,379 +5.5% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 8,825,881 +465,961 +5.6% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 8,798,956 +439,751 +5.3% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 8,721,031 +410,266 +4.9% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 8,351,003 +700,436 +9.2% 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 8,359,920 -74,718,755 -90% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 8,359,205 -74,671,265 -90% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 8,310,765 -48,159,482 -85% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 7,650,567 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 83,078,675 +36,211,556 +77% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 83,030,470 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 56,470,247 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q3 2020 46,867,119 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q3 2017 10,219,138 +2,938,138 +40% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 8,576,634 +2,051,884 +31% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q3 2016 7,281,000 +535,584 +7.9% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 6,524,750 -27,000,906 -81% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q3 2015 6,745,416 -10,565,292 -61% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 33,525,656 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q3 2014 17,310,708 01 Jul 2014 30 Sep 2014 10-Q/A 14 Apr 2016 2015 Q3
Q3 2012 73,128,058 +25,914,348 +55% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2012 2012 Q3
Q3 2011 47,213,710 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012 2012 Q3

Marker Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 8,980,207 +170,825 +1.9% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 8,809,382 +458,379 +5.5% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 8,351,003 +700,436 +9.2% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 7,650,567 -39,389,295 -84% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
2020 47,039,862 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2017 9,453,483 +2,032,488 +27% 01 Jan 2017 31 Dec 2017 10-K 23 Mar 2018 2017 FY
2016 7,420,995 +3,758,739 +103% 01 Jan 2016 31 Dec 2016 10-K 23 Mar 2018 2017 FY
2015 3,662,256 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.